{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:11006",
      "entity_text" : "CNS",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:6918248",
      "entity_text" : "Flibanserin",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Flibanserin is known to cause CNS depression, hypotension, and syncope, and a Risk Evaluation and Mitigation Strategy (REMS) post market surveillance program to monitor these effects is in place.",
  "reading_complete" : "2020-08-04T12:12:12Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T11:50:15Z",
  "trigger" : "cause",
  "evidence" : [ "Flibanserin is known to cause CNS" ],
  "pmc_id" : "5330968",
  "score" : 0
}